Bliss GVS Pharma Ltd (BLISSGVS) — Insider Trading | 2 September 2026

2 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Open offer acceptance finalized for 1,669 shares at ₹299 per share.

🔄 What Changed

Acquirer now holds additional shares, increasing its stake in Bliss GVS Pharma.

💡 Investor Takeaway

This acquisition strengthens the acquirer's position in Bliss GVS Pharma through a regulated open offer process.

Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited, via SBI Capital Markets, completed a 26% open offer for Bliss GVS Pharma at ₹299 per share, accepting 1,669 shares. The post-offer advertisement confirms regulatory compliance and obligations under SEBI (SAST) Regulations, with payment finalized on August 24, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BLISSGVS ✨ Ask AI About This

About Bliss GVS Pharma Ltd (BLISSGVS)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹7,530.52 CrP/E: 55.1ROE: 11.4%ROCE: 17.5%Div Yield: 0.14%

View full BLISSGVS stock details →

📡 Get AI alerts when BLISSGVS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BLISSGVS — Free

💡 Ask AI about this filing

"What is the current shareholding pattern post-acquisition?""How does this affect Bliss GVS Pharma's valuation?""What are the long-term integration plans for the acquired stake?"

Ask AI Free →

📊 More BLISSGVS filings

Announcement — 29 September 2026Bliss GVS Pharma announced that its trading window closes on October 1, 2026, ahead of unaudited qua...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced on September 28, 2026 that Anupam Rasayan India Limited, via its subsidia...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced a board meeting on October 1, 2026, to consider establishing two employee...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced the completion of Anupam Rasayan India's acquisition of 47.95% stake, mak...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced that its board approved the reclassification of 22 outgoing promoters fro...

See all BLISSGVS filings →

🔥 Also filed on 2 September 2026

WAAREEENERWaaree Energies LtdAnnual Report PEARLPOLYPearl Polymers LtdAnnual Report 544627Purple Wave Infocom LtdAnnual Report 544437Marc Loire Fashions LtdAnnual Report RTNINDIARattanIndia Enterprises LtdAnnual Report 544596Safecure Services LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BLISSGVS files new disclosures

Track BLISSGVS filings, board meetings, and corporate actions. Free email alerts at 5 PM.